Condition: Heart Failure With Reduced Ejection Fraction · Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
This is a prospective cohort study, where the investigators aim to investigate the effect of implementation of an electronic nudge alerting clinicians to the prescription of the 4 key pharmacological classes for the treatment of patients with heart failure and reduced ejection fraction (HFrEF) at the outpatient clinic in the Netherlands.
This description comes directly from the study's public registry record.
Folkert Assselbergs, MD PhD · 0031205669111 · f.w.asselbergs@amsterdamumc.nl
A Uijl · a.uijl@amsterdamumc.nl
Always discuss trial participation with your own doctor first.
| Amsterdam University Medical Centers, Location AMC | Amsterdam, Netherlands | Recruiting |
| Amsterdam University Medical Centers, Location VU Medical Center | Amsterdam, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06344910